• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

轻度哮喘真的轻度吗?患者的现实生活环境。

Is mild asthma truly mild? The patients' real-life setting.

机构信息

Department of Cardiac Thoracic Vascular Sciences and Public Health, University of Padova, Padua, Italy.

Department of Medicine, University of Verona, Verona, Italy.

出版信息

Expert Rev Respir Med. 2022 Nov-Dec;16(11-12):1263-1272. doi: 10.1080/17476348.2023.2167714. Epub 2023 Jan 18.

DOI:10.1080/17476348.2023.2167714
PMID:36633404
Abstract

OBJECTIVES

Asthma exacerbations and, more rarely, fatal asthma attacks have been reported in mild asthma patients, suggesting poor disease control and awareness of its potential burden. Our study aimed to explore outside the hospital/specialist setting the perspective and disease treatment behavior of patients self-reporting a mild asthma diagnosis.

METHODS

Computer-Assisted Personal Interviewing (CAPI) technique was used to investigate the identified study population. Questions about diagnosis, symptoms, comorbidities, treatment strategy, ongoing assessments, and quality of life were administered.

RESULTS

Overall, 258 patients were considered for the analysis. As the most relevant results, 22% of them reported severe respiratory symptoms, 52% experienced at least one exacerbation/year, and 7% needed Emergency Room care. Sixty-six percent of the respondents assumed as needing short-acting bronchodilators only. Of note, 22% of patients were using oral steroids (OCS) intermittently and 72% of them considered their quality of life unsatisfying.

CONCLUSION

Outside the hospital/specialist setting, mild asthma burden is still not negligible and the treatment approach is not correct. In particular, the reported OCS use is disproportionate. Our data suggest that mild asthma, especially when self-assessed might be other than mild, suggesting that efforts to increase disease awareness, improve the disease control limiting the OCS abuse are required.

摘要

目的

在轻度哮喘患者中,已报告哮喘加重,更罕见的是致命性哮喘发作,这表明疾病控制不佳且对其潜在负担认识不足。我们的研究旨在探索在院外/专科环境之外,自我报告轻度哮喘诊断的患者的观点和疾病治疗行为。

方法

采用计算机辅助个人访谈(CAPI)技术对确定的研究人群进行调查。询问诊断、症状、合并症、治疗策略、持续评估和生活质量等问题。

结果

总体而言,对 258 名患者进行了分析。作为最相关的结果,其中 22%的患者报告有严重的呼吸道症状,52%的患者每年至少经历一次加重,7%的患者需要急诊治疗。66%的受访者认为仅需要短效支气管扩张剂。值得注意的是,22%的患者间歇性使用口服皮质类固醇(OCS),72%的患者认为他们的生活质量不满意。

结论

在院外/专科环境之外,轻度哮喘的负担仍然不可忽视,治疗方法也不正确。特别是报告的 OCS 使用不成比例。我们的数据表明,轻度哮喘,尤其是自我评估的轻度哮喘,可能并非真正的轻度,这表明需要努力提高疾病意识,改善疾病控制,限制 OCS 的滥用。

相似文献

1
Is mild asthma truly mild? The patients' real-life setting.轻度哮喘真的轻度吗?患者的现实生活环境。
Expert Rev Respir Med. 2022 Nov-Dec;16(11-12):1263-1272. doi: 10.1080/17476348.2023.2167714. Epub 2023 Jan 18.
2
Burden of Chronic Oral Corticosteroid Use by Adults with Persistent Asthma.慢性口服皮质类固醇治疗持续性哮喘成人的负担。
J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):1050-1060.e9. doi: 10.1016/j.jaip.2016.12.023. Epub 2017 Feb 10.
3
Burden and unmet need for specialist care in poorly controlled and severe childhood asthma in a Danish nationwide cohort.丹麦全国队列研究显示,在儿童哮喘控制不佳和严重的情况下,患者的负担和专科护理需求未得到满足。
Respir Res. 2023 Jun 27;24(1):173. doi: 10.1186/s12931-023-02482-7.
4
Acute severe asthma: new approaches to assessment and treatment.急性重症哮喘:评估和治疗的新方法。
Drugs. 2009;69(17):2363-91. doi: 10.2165/11319930-000000000-00000.
5
Interventions for escalation of therapy for acute exacerbations of asthma in children: an overview of Cochrane Reviews.儿童哮喘急性加重期治疗升级的干预措施:Cochrane系统评价综述
Cochrane Database Syst Rev. 2020 Aug 5;8(8):CD012977. doi: 10.1002/14651858.CD012977.pub2.
6
Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children.福莫特罗与布地奈德联合用于成人和儿童慢性哮喘的维持和缓解治疗与联合吸入器维持治疗的对比
Cochrane Database Syst Rev. 2013 Dec 16;2013(12):CD009019. doi: 10.1002/14651858.CD009019.pub2.
7
Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma.长效毒蕈碱拮抗剂(LAMA)与吸入性糖皮质激素(ICS)联合使用,对比单独使用相同剂量ICS用于成人哮喘患者的疗效。
Cochrane Database Syst Rev. 2015 Aug 24;2015(8):CD011397. doi: 10.1002/14651858.CD011397.pub2.
8
Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children.福莫特罗与布地奈德联合用于成人和儿童慢性哮喘的维持和缓解治疗与当前最佳实践(包括吸入性糖皮质激素维持治疗)的对比研究
Cochrane Database Syst Rev. 2013 Apr 30;2013(4):CD007313. doi: 10.1002/14651858.CD007313.pub3.
9
Clinical Remission in Severe Asthma: A Pooled Post Hoc Analysis of the Patient Journey with Benralizumab.严重哮喘的临床缓解:贝那鲁肽治疗患者的路径的汇总事后分析。
Adv Ther. 2022 May;39(5):2065-2084. doi: 10.1007/s12325-022-02098-1. Epub 2022 Mar 14.
10
SYmbicort given as needed in mild asthma (SYGMA study): a retrospective subanalysis of the Russian population.按需使用信必可都保治疗轻度哮喘(SYGMA研究):俄罗斯人群的回顾性亚组分析
J Asthma. 2022 May;59(5):989-997. doi: 10.1080/02770903.2021.1892753. Epub 2021 Mar 8.

引用本文的文献

1
Symptoms of Asthma Extracted Through Natural Language Processing and Their Associations With Acute Asthma Exacerbation in Adults With Mild Asthma.通过自然语言处理提取的哮喘症状及其与轻度哮喘成人急性哮喘加重的关联
J Allergy Clin Immunol Pract. 2025 Jul;13(7):1719-1729.e7. doi: 10.1016/j.jaip.2025.04.031. Epub 2025 Apr 26.
2
Real-world use of inhaled corticosteroid/formoterol as needed in adults with mild asthma: the PRIME study.成人轻度哮喘患者按需使用吸入性糖皮质激素/福莫特罗的真实世界研究:PRIME研究
ERJ Open Res. 2024 Sep 30;10(5). doi: 10.1183/23120541.00174-2024. eCollection 2024 Sep.
3
Risk Factors Associated with Asthma Control and Quality of Life in Patients with Mild Asthma Without Preventer Treatment, a Cross-Sectional Study.
一项横断面研究:未接受预防治疗的轻度哮喘患者中与哮喘控制及生活质量相关的危险因素
J Asthma Allergy. 2024 Jul 9;17:621-632. doi: 10.2147/JAA.S460051. eCollection 2024.
4
Risk Factors for Acute Asthma Exacerbations in Adults With Mild Asthma.轻度哮喘成人急性哮喘加重的危险因素
J Allergy Clin Immunol Pract. 2024 Oct;12(10):2705-2716.e6. doi: 10.1016/j.jaip.2024.05.034. Epub 2024 May 29.